Robert Hedequist
Präsident bei Kineta Immuno-Oncology LLC
Profil
Robert Hedequist is currently the President & Chief Operating Officer at Kineta Chronic Pain LLC and Kineta Immuno-Oncology LLC.
He previously worked as a Director at Kv1.3 Therapeutics, Inc. and as the President & Chief Operating Officer at Kineta, Inc. (Washington).
Aktive Positionen von Robert Hedequist
| Unternehmen | Position | Beginn |
|---|---|---|
Kineta Immuno-Oncology LLC
 Kineta Immuno-Oncology LLC BiotechnologyHealth Technology Kineta Immuno-Oncology LLC operates as a biotech company. It specializes in RIG-I pathway, tumor immunity, publications and posters. The company was founded in 2016 and is headquartered in Seattle, WA. | Präsident | - |
Kineta Chronic Pain LLC
 Kineta Chronic Pain LLC Miscellaneous Commercial ServicesCommercial Services Kineta Chronic Pain LLC operates as a biotechnology company. It develops a pipeline of therapies that address critical unmet patient needs in oncology, chronic pain and biodefense systems. The company was founded in 2011 and is headquartered in Seattle, WA. | Präsident | - |
Ehemalige bekannte Positionen von Robert Hedequist
| Unternehmen | Position | Ende |
|---|---|---|
Kv1.3 Therapeutics, Inc.
 Kv1.3 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kv1.3 Therapeutics, Inc. operates as a clinical stage biopharmaceutical firm. It focuses on providing new treatment options for rare autoimmune diseases. The company was founded in 2009 and is headquartered in Seattle, WA. | Direktor/Vorstandsmitglied | - |
Kineta, Inc. (Washington)
 Kineta, Inc. (Washington) Pharmaceuticals: MajorHealth Technology Kineta, Inc. engages in the development of novel immuno-therapies. It develops a pipeline of therapies that address critical unmet patient needs in oncology, chronic pain and biodefense. The company was founded by Shawn P. Iadonato and Charles L. Magness in 2008 and is headquartered in Seattle, WA. | Präsident | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Kineta Immuno-Oncology LLC
Kineta Immuno-Oncology LLC BiotechnologyHealth Technology Kineta Immuno-Oncology LLC operates as a biotech company. It specializes in RIG-I pathway, tumor immunity, publications and posters. The company was founded in 2016 and is headquartered in Seattle, WA. | Health Technology |
Kineta, Inc. (Washington)
Kineta, Inc. (Washington) Pharmaceuticals: MajorHealth Technology Kineta, Inc. engages in the development of novel immuno-therapies. It develops a pipeline of therapies that address critical unmet patient needs in oncology, chronic pain and biodefense. The company was founded by Shawn P. Iadonato and Charles L. Magness in 2008 and is headquartered in Seattle, WA. | Health Technology |
Kineta Chronic Pain LLC
Kineta Chronic Pain LLC Miscellaneous Commercial ServicesCommercial Services Kineta Chronic Pain LLC operates as a biotechnology company. It develops a pipeline of therapies that address critical unmet patient needs in oncology, chronic pain and biodefense systems. The company was founded in 2011 and is headquartered in Seattle, WA. | Commercial Services |
Kv1.3 Therapeutics, Inc.
Kv1.3 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kv1.3 Therapeutics, Inc. operates as a clinical stage biopharmaceutical firm. It focuses on providing new treatment options for rare autoimmune diseases. The company was founded in 2009 and is headquartered in Seattle, WA. | Health Technology |
